论文部分内容阅读
目的:探讨多索茶碱在支气管哮喘急性发作轻、中度患者中的应用效果。方法:将收治的支气管哮喘急性发作轻、中度患者随机分为观察组(28例)和对照组(28例)。在常规治疗基础上,对照组予氨茶碱,观察组予多索茶碱。比较两组的治疗有效率,主要症状、体征恢复或消失时间及不良反应情况。结果:观察组治疗总有效率为92.9%,明显高于对照组的78.6%(P<0.05);干预后,观察组咳嗽(5.20±1.01)d、哮鸣音(3.23±1.09)d和喘息(2.31±0.59)d的消失时间均少于对照组的(8.07±2.87)d、(4.09±1.67)d、(3.87±1.03)d,差异有统计学意义(P<0.05或P<0.01);两组不良反应发生率差异不明显。结论:多索茶碱治疗支气管哮喘急性发作轻、中度的临床疗效显著,安全性好,值得推广。
Objective: To investigate the effect of doxofylline in patients with mild and moderate bronchial asthma exacerbation. Methods: The mild and moderate acute bronchial asthma patients admitted were randomly divided into observation group (28 cases) and control group (28 cases). On the basis of routine treatment, the control group was given aminophylline, and the observation group was given doxofylline. Compare the two groups of treatment efficiency, the main symptoms, signs of recovery or disappearance of time and adverse reactions. Results: The total effective rate of the observation group was 92.9%, significantly higher than that of the control group (78.6%, P <0.05). After the intervention, the cough (5.20 ± 1.01) d, wheeze (3.23 ± 1.09) (2.31 ± 0.59) d were less than those in the control group (8.07 ± 2.87) d, (4.09 ± 1.67) d and (3.87 ± 1.03) d, respectively, with significant difference (P <0.05 or P <0.01) There was no obvious difference between the two groups in the incidence of adverse reactions. Conclusion: Doxofylline treatment of acute exacerbation of bronchial asthma with mild to moderate clinical efficacy was significant, good safety, it is worth promoting.